This Darden Analyst Turns Bullish; Here Are Top 4 Upgrades For Monday

Darden Restaurants, Inc.
Janux Therapeutics, Inc.
ArcelorMittal SA ADR
Aeva Technologies, Inc.
Nuvectis Pharma, Inc.

Darden Restaurants, Inc.

DRI

0.00

Janux Therapeutics, Inc.

JANX

0.00

ArcelorMittal SA ADR

MT

0.00

Aeva Technologies, Inc.

AEVA

0.00

Nuvectis Pharma, Inc.

NVCT

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Baird analyst Chris O’Cull upgraded Darden Restaurants Inc (NYSE:DRI) from Neutral to Outperform and raised the price target from $220 to $250. Darden closed at $221.60 on Friday. See how other analysts view this stock.
  • Wolfe Research analyst Kalpit Patel upgraded Janux Therapeutics Inc (NASDAQ:JANX) from Peer Perform to Outperform and announced a $23 price target. Janux Therapeutics shares closed at $17.9390 on Friday. See how other analysts view this stock.
  • UBS analyst David Vogt upgraded Celestica Inc (NYSE:CLS) from Neutral to Buy and raised the price target from $410 to $430. Celestica closed at $296.55 on Friday. See how other analysts view this stock.
  • Wolfe Research analyst Trevor Allinson upgraded PulteGroup, Inc. (NYSE:PHM) from Peer Perform to Outperform and announced a $129 price target. PulteGroup shares closed at $129.00 on Friday. See how other analysts view this stock.

Considering buying DRI stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.